Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0017636 (
glioblastoma
)
18,345
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Our previous study showed that the gene expression of beta-1,4-galactosyltransferase V (beta-1,4-
GalT
V), preferentially galactosylating GlcNAc1-->6Man of oligosaccharides, increased in the process of astrocytoma progress, with the highest level in
grade IV astrocytoma
. To investigate the function of this beta-1,4-
GalT
in cell proliferation, the sense and antisense cDNA of beta-1,4-
GalT
V was constructed as pcDNA3-HA-
GalT
V and pcDNA3-anti-
GalT
V respectively and transfected into SHG cell, a kind of human astrocytoma cell line. The transfection was confirmed with Northern and Western blot assay. It was found that the growth of SHG/HA-
GalT
V in serum-containing medium was faster than that of mock-transfectant with the vector pcDNA3, whereas the growth of SHG/GalTV-AS was slower than that of mock-transfectant. GalTV-HA/SHG showed a stronger capability for colony formation than that of GalTV-AS/SHG as evaluated by anchorage-independent growth in soft agar assay. This result was consistent with that of the growth curve. By RCA-1 lectin assay, the galactosylation on the surface of GalTV-HA/SHG and SHG/GalTV-AS was stained stronger (P<0.001) and weaker (P<0.05) respectively compared with the mock transfectant. This indicates that beta-1,4-
GalT
V was involved in the malignant phenotype of astrocytoma cells, possibly causing the high galactosylation on the cell surface.
...
PMID:Over-expression of beta-1,4-galactosyltransferase V increases the growth of astrocytoma cell line. 1238 86